Gastritis
Key Points
- Gastritis is inflammation of the gastric mucosa and may be acute or chronic, erosive or nonerosive.
- Acute gastritis is commonly linked to irritants such as NSAIDs/aspirin, alcohol, smoking, infection, or severe stress.
- Chronic gastritis is often associated with H. pylori infection and can also occur with autoimmune disease, Crohn disease, gastric surgery, or HIV.
- Untreated gastritis increases risk for peptic ulcer disease, bleeding, perforation, and gastric-cancer progression.
- Nursing priorities are symptom control, cause-focused education, bleeding surveillance, and adherence to treatment.
Pathophysiology
Gastritis develops when mucosal defense is disrupted and gastric-lining inflammation progresses. In acute patterns, direct irritant injury or stress-related reduction in mucosal bicarbonate protection can produce rapid symptom onset.
In chronic patterns, persistent inflammation is often tied to H. pylori-associated mucosal injury, but autoimmune and inflammatory disease pathways can also contribute. Ongoing untreated inflammation increases risk for ulceration and bleeding complications.
Classification
- Acute gastritis: Short-course inflammatory pattern often linked to irritants or physiologic stress.
- Chronic gastritis: Longer-course inflammatory pattern, frequently related to H. pylori or immune-mediated causes.
- Erosive pattern: Mucosal injury with higher bleeding risk.
- Nonerosive pattern: Inflammation without major erosive surface injury.
Nursing Assessment
NCLEX Focus
Distinguish uncomplicated dyspeptic symptoms from bleeding or alarm cues needing urgent escalation.
- Assess acute symptom cues such as epigastric pain, nausea, vomiting, and postprandial upper-abdominal fullness.
- Recognize that chronic gastritis can be minimally symptomatic or asymptomatic.
- Assess additional symptom history including belching/hiccups, appetite loss, and blood in stool or emesis.
- Screen exposure risks including smoking, alcohol use, regular NSAID/aspirin use, and high stress burden.
- Escalate alarm findings such as GI bleeding, anemia signs, recurrent vomiting, progressive dysphagia/odynophagia, early satiety, and unexplained weight loss.
Diagnostics
- History-first evaluation: Detailed medical and social history helps separate gastritis from overlapping upper-GI disorders.
- Endoscopy with biopsy (gold standard): Confirms gastritis pattern and mucosal injury.
- H. pylori testing: Endoscopy/biopsy-based testing or urease breath testing can confirm infection.
- Adjunct studies: Upper-GI series may evaluate concurrent reflux, dysphagia, hiatal hernia, ulcer, tumor, or achalasia patterns.
- Laboratory support: Blood testing can evaluate H. pylori and iron-deficiency anemia from occult GI blood loss; stool testing may detect blood or infectious contributors.
Nursing Interventions
- Reinforce avoidance of gastric irritants (trigger foods/drinks and ulcerogenic medications when feasible).
- Support smoking and alcohol cessation counseling.
- Monitor stool and emesis for bleeding cues and notify the provider immediately for frank blood or black-tarry stool.
- Track symptom timing, severity, and potential triggers to evaluate treatment response.
- Reinforce education on treatment adherence and follow-up testing for cause confirmation and eradication plans.
- Coordinate care plans that include diet modification, stress management, and medication review/deprescribing when indicated.
Pharmacology
| Drug Class | Role in Gastritis Care | Key Nursing Considerations |
|---|---|---|
| proton-pump-inhibitors | Acid suppression and mucosal healing support | Reinforce adherence and monitor long-term electrolyte/micronutrient risks when therapy is prolonged. |
| antibiotics | H. pylori eradication when infection is confirmed | Confirm regimen completion and follow-up eradication testing plan. |
| Micronutrient replacement | Corrects selected deficiency patterns | Match replacement to documented deficits and trend clinical response. |
| Immunomodulatory therapy | Selected autoimmune/inflammatory etiologies | Monitor treatment response and adverse effects in specialty-directed plans. |
Clinical Judgment Application
Clinical Scenario
A patient reports epigastric pain, nausea after meals, and intermittent black stools with daily NSAID use.
- Recognize Cues: Upper-GI pain plus possible melena and high-risk medication exposure.
- Analyze Cues: Findings suggest gastritis with possible bleeding complication.
- Prioritize Hypotheses: Immediate priority is bleeding-risk evaluation and cause-directed workup.
- Generate Solutions: Escalate for diagnostic testing, medication review, and acid-suppression plus eradication planning as indicated.
- Take Action: Notify provider of bleeding cues, implement monitoring, and reinforce irritant-avoidance education.
- Evaluate Outcomes: Symptoms and bleeding cues resolve while treatment adherence and trigger reduction improve.
Related Concepts
- peptic-ulcer-disease-gastric-and-duodenal-ulceration - Common complication pathway when gastritis is untreated.
- gastroesophageal-reflux-disease-gerd - Overlapping upper-GI symptom pattern requiring differential assessment.
- proton-pump-inhibitors - Core acid-suppression pathway used in gastritis and ulcer care.
- comprehensive-abdominal-assessment - Structured upper-abdominal symptom and red-flag evaluation.